Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility
- PMID: 40614140
- PMCID: PMC12236113
- DOI: 10.12659/MSM.947895
Comparative Analysis of Afamin, Asprosin, and Pentraxin 3 Levels in Women with PCOS and Women with Unexplained Infertility
Abstract
BACKGROUND Infertility is defined as the absence of pregnancy despite unprotected, regular sexual intercourse of couples of reproductive age for at least 1 year. Infertility may be unexplained or linked to anovulation/polycystic ovary syndrome (PCOS). PCOS can involve the processes of inflammation, insulin resistance, and metabolic syndrome. This study compared serum levels of afamin, asprosin, and pentraxin3 (PTX3) between women with PCOS and women with unexplained infertility to elucidate underlying pathophysiological mechanisms. MATERIAL AND METHODS Our study included 106 women: 55 with unexplained infertility and 51 with PCOS. Using the electrochemiluminescence immunoassay method, we assessed the levels of estradiol, follicle-stimulating hormone, luteinizing hormone, and anti-Mullerian hormone. Afamin, asprosin, and PTX3 levels were measured by ELISA. RESULTS Age, fasting glucose levels, and body mass index (BMI) of the groups were statistically similar. Anti-Mullerian hormone, antral follicle count, and LH levels were higher (P<0.05) in the PCOS group. Afamin and PTX3 levels were higher in the PCOS group (P<0.05), while asprosin levels were similar. CONCLUSIONS Our study demonstrates the importance of afamin associated with oxidative stress and the PTX3, which plays a role in the regulation of humoral immune responses, in the etiology of infertility cases. Afamin and PTX3 should be evaluated in ovulatory and non-ovulatory PCOS cycles to facilitate treatment and to elucidate the ovulation and implantation processes in PCOS. These recommendations specifically include dividing PCOS patients into subgroups such as diabetogenic, obese, and hirsute, and re-examining biochemical markers accordingly.
Conflict of interest statement
Similar articles
-
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6. Cochrane Database Syst Rev. 2017. PMID: 29183107 Free PMC article.
-
Polycystic ovary syndrome and excessive body weight impact independently and synergically on fertility treatment outcomes.Reprod Biol Endocrinol. 2025 Jul 7;23(1):97. doi: 10.1186/s12958-025-01434-8. Reprod Biol Endocrinol. 2025. PMID: 40624700 Free PMC article.
-
Evaluating serum anti-Müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome in Pakistani women.Int J Gynaecol Obstet. 2025 Jun 25. doi: 10.1002/ijgo.70240. Online ahead of print. Int J Gynaecol Obstet. 2025. PMID: 40560122
-
Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome.Cochrane Database Syst Rev. 2000;(4):CD000410. doi: 10.1002/14651858.CD000410. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2015 Aug 24;(8):CD000410. doi: 10.1002/14651858.CD000410.pub2. PMID: 11034687 Updated.
-
Anti-Müllerian hormone as a diagnostic and prognostic marker in polycystic ovary syndrome: a clinical study.Cell Mol Biol (Noisy-le-grand). 2025 Jul 6;71(6):30-34. doi: 10.14715/cmb/2025.71.6.4. Cell Mol Biol (Noisy-le-grand). 2025. PMID: 40618338
References
-
- Vayena E, Rowe P, Griffin P. Current practices and controversies in assisted reproduction. report of a meeting on medical, ethical and social aspects of assisted reproduction held at WHO headquarters; 2001 Sep 17–21; Geneva, Switzerland. Available from: https://iris.who.int/bitstream/handle/10665/42576/9241590300.pdf.
-
- Thonneau P, Marchand S, Tallec A, et al. Incidence and main causes of infertility in a resident population of three French regions. Hum Reprod. 1991;6:811–16. - PubMed
-
- Wang R, Mol BW. The Rotterdam criteria for polycystic ovary syndrome: Evidence-based criteria? Hum Reprod. 2017;32(2):261–64. - PubMed
-
- Subramaniam AG, Joseph A, Gupta A, et al. Reduced Tregs in peripheral blood of PCOS patients – a consequence of aberrant Il2 signaling. J Clin Endocrinol Metab. 2015;100(1):282–92. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous